×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | 3.25 | -4.52 | NA | -18.44 | 0 | |
| PHAARMASIA LTD. | 56.14 | -5.25 | 54.30 | -0.77 | 21.9 | |
| COLINZ LABORATORIES LTD. | 15.27 | 1.50 | 14.51 | 0.60 | 20.7 | 41.4 |
| CHEMO PHARMA LABORATORIES LTD. | -1.64 | -3.40 | NA | -2.26 | 19.1 | 56.3 |
Phaarmasia Limited., with Security Code 523620, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7.9 | 7.5 | 6.9 | 8.6 | 5.1 | 10.0 | 8.3 | 5.9 | 4.7 | 5.4 |
| Expenses | 8.6 | 7.7 | 7.2 | 8.9 | 5.6 | 9.7 | 8.1 | 6.7 | 5.5 | 6.0 |
| Operating Profit | -0.6 | -0.2 | -0.3 | -0.3 | -0.6 | 0.3 | 0.2 | -0.8 | -0.8 | -0.6 |
| OPM % | -8.06% | -2.8% | -4.65% | -3.16% | -10.98% | 3.32% | 2.22% | -13.28% | -16.79% | -10.85% |
| Other Income | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 |
| Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Depreciation | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Profit before tax | -0.6 | -0.3 | -0.3 | -0.2 | -0.5 | 0.4 | 0.2 | -0.6 | -0.7 | -0.5 |
| Tax % | -0.5% | 0% | -1.5% | -5.3% | 4.3% | 8.7% | 11.2% | -0.6% | 0.9% | 0% |
| Net Profit | -0.6 | -0.3 | -0.3 | -0.2 | -0.6 | 0.5 | 0.3 | -0.6 | -0.7 | -0.5 |
| EPS in Rs | -0.87 | -0.28 | -0.39 | -0.24 | -0.83 | 0.69 | 0.4 | -0.94 | -1.02 | 0 |
| Metrics | Jun 2023 |
|---|---|
| Sales | 6.9 |
| Expenses | 7.2 |
| Operating Profit | -0.3 |
| OPM % | -4.65% |
| Other Income | 0.1 |
| Interest | 0.0 |
| Depreciation | 0.1 |
| Profit before tax | -0.3 |
| Tax % | -1.5% |
| Net Profit | -0.3 |
| EPS in Rs | -0.39 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 5% |
| 3 Years: | 24% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 45% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 10% |
| 3 Years: | 3% |
| 1 Year: | -18% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|